Cathepsin B expression is associated with arterial stiffening and atherosclerotic vascular disease

Eur J Prev Cardiol. 2020 Dec;27(19):2288-2291. doi: 10.1177/2047487319893042. Epub 2019 Dec 4.

Authors

Alexia Mareti¹, Chrysoula Kritsioti¹, Georgios Georgiopoulos¹, Nikolaos I Vlachogiannis^{2

3}, Dimitris Delialis¹, Marco Sachse⁴, Kateryna Sopova^{2

3}, Athanasios Koutsoukis¹, Christos Kontogiannis¹, Raphael Patras¹, Simon Tual-Chalot^{2

3}, Andreas Koureas⁵, Aikaterini Gatsiou^{2

3}, Konstantinos Stellos^{2

3}, Kimon Stamatelopoulos^{1

2}

Affiliations

¹ Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, Athens, Greece.
² Cardiovascular Disease Prevention Hub, Cardiovascular Research Theme Vascular Biology and Medicine, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
³ Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
⁴ Medical School, Goethe University Frankfurt, Frankfurt am Main, Germany.
⁵ Department of Radiology, Aretaieion Hospital, Athens University, Medical School, Athens, Greece.

PMID: 31801046
DOI: 10.1177/2047487319893042

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Age Factors
Atherosclerosis / diagnostic imaging
Atherosclerosis / metabolism*
Biomarkers / metabolism
Cathepsin B / metabolism*
Female
Humans
Male
Risk Factors
Ultrasonography
Vascular Stiffness*

Substances

Biomarkers
Cathepsin B